Valeo Pharma Inc., a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products, and Besins Healthcare, a global pharmaceutical company world leader in […]
Orleans-based Tetra Bio-Pharma submits multiple applications of Orphan Drug Designation for cannabinoids to the U.S. Food and Drug Administration (FDA) for various forms of rare […]
Simon Fraser University (SFU) and Nanotech Security join forces to commission a $4.5-million electron beam lithography system at SFU’s 4D LABS which will create nanotechnology up […]
The National Research Council of Canada (NRC) and AP&C, a GE Additive company, develop a new way to test the quality of powders used in […]
In 1986, the FDA approved a new transplant rejection drug that was derived from an intact monoclonal antibody (mAb).1 Although it would be almost a […]
Halifax-based Appili Therapeutics Inc. announces that they have received positive top-line results from a pivotal relative bioavailability study evaluating pharmacokinetics, safety, and palatability of ATI-1501 […]
Guelph-based PlantForm Corporation of Canada is stretching across the ocean to collaborate with South Africa’s Council for Scientific and Industrial Research (CSIR) and BGM Pharmaceuticals […]
Health Canada grants Gilead Sciences Canada Inc. a Notice of Compliance for Biktarvy (bictegravir), a once-daily single tablet regimen (STR) for the treatment of HIV-1 […]
Lonza launches its new bioscience website that is chalked full of detailed application and product information. The website has been designed to support the work […]
Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, announces that Health Canada has approved Probuphine (buprenorphine subdermal implant) for the management of opioid dependence […]
Copyright © 2018 | WordPress Theme by MH Themes
